78 results on '"Skali, Hicham"'
Search Results
2. Sex Differences in Association of Physical Activity With All-Cause and Cardiovascular Mortality
3. Use of Optimal Medical Therapy in Patients With Cardiovascular Disease Undergoing Cardiac Rehabilitation
4. Changes in Pulmonary Artery Pressure Late in Life
5. Pulmonary embolism with thrombus-in-transit across a patent foramen ovale
6. Extrathoracic Against Intrathoracic Vascular Accesses for Transcatheter Aortic Valve Replacement: A Systematic Review With Meta-Analysis
7. Longitudinal Changes in Left Ventricular Diastolic Function in Late Life
8. Right Ventricular Function and Coupling to Pulmonary Circulation in Heart Failure with Preserved Ejection Fraction: The PARAGON-HF Trial
9. Chronic Kidney Disease, Heart Failure, and Adverse Cardiac Remodeling in Older Adults
10. ASSOCIATION OF BASELINE MODEST ALCOHOL CONSUMPTION AND CORONARY MICROVASCULAR DYSFUNCTION IN THE CARDIOVASCULAR INFLAMMATION REDUCTION TRIAL (CIRT-CFR)
11. Coronary Flow Reserve, Inflammation, and Myocardial Strain
12. Weight Loss and Its Predictors During Participation in Cardiac Rehabilitation
13. Impact of coronary artery calcium testing on patient management
14. Diabetes and Progression of Heart Failure
15. Association of Left Atrial Structure and Function With Heart Failure in Older Adults
16. PROGRESSION IN VALVULAR HEART DISEASE STAGES OVER SIX YEARS IN LATE-LIFE: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY
17. IMPACT OF VALVULAR HEART DISEASE STAGES ON CARDIAC STRUCTURE AND FUNCTION AMONG OLDER ADULTS IN THE COMMUNITY: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY
18. PHYSICAL AND PSYCHOSOCIAL EFFECTS OF CARDIAC REHABILITATION PARTICIPATION IN WOMEN COMPARED TO MEN
19. CLINICAL AND ECONOMIC OUTCOMES OF PHARMACOLOGICAL STRESS TESTS IN PATIENTS WITH A HISTORY OF COVID-19
20. Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease
21. Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure
22. Coronary Flow Reserve, Inflammation and Myocardial Strain in the Cardiovascular Inflammation Reduction Trial (CIRT-CFR)
23. PREDICTORS OF CARDIAC REHABILITATION COMPLETION
24. CAD is a Risk Factor for Heart Failure with Preserved Ejection Fraction: The ARIC Study
25. Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial
26. DIAGNOSTIC ACCURACY OF ADVANCED IMAGING IN CARDIAC SARCOIDOSIS: AN IMAGING-HISTOLOGIC CORRELATION STUDY IN PATIENTS UNDERGOING CARDIAC TRANSPLANTATION
27. SEX AND RACE DIFFERENCES IN CIRCULATING LEVELS OF NATRIURETIC PEPTIDE CONCENTRATIONS AND THE ASSOCIATION WITH INCIDENT HEART FAILURE IN THE COMMUNITY: THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY
28. CMR AND ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT VENTRICULAR STRAIN IN TRANSTHYRETIN CARDIAC AMYLOIDOSIS
29. EXERCISE TREADMILL TESTING HAS LOW UTILITY IN THE EVALUATION OF CORONARY MICROVASCULAR DISEASE
30. ASSOCIATION OF RIGHT VENTRICULAR DYSFUNCTION WITH FUNCTIONAL CAPACITY AND RESPIRATORY EFFICIENCY IN HEART FAILURE AND THE IMPACT OF LVEF
31. Resting Heart Rate and Chronotropic Response to Exercise: Prognostic Implications in Heart Failure Across the Left Ventricular Ejection Fraction Spectrum
32. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage
33. Cardiac Troponin
34. Erratum to: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity
35. CARDIAC MRI AND PET HAVE COMPLEMENTARY VALUE IN THE ASSESSMENT OF SUSPECTED CARDIAC SARCOIDOSIS
36. Association of High-Sensitivity Cardiac Troponin T and Natriuretic Peptide With Incident ESRD: The Atherosclerosis Risk in Communities (ARIC) Study
37. POST-EXERCISE HYPOTENSION: MARKER OF SIGNIFICANT CAD?
38. Heart Failure Risk Across the Spectrum of Ankle-Brachial Index
39. Influence of Diabetes Mellitus on Cardiac Structure and Function and Response to Therapy with LCZ696 in Heart Failure with Preserved Ejection Fraction
40. Comparison of the Use of Downstream Tests After Exercise Treadmill Testing by Cardiologists Versus Noncardiologists
41. Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device
42. TEMPORAL TRENDS IN THE POPULATION ATTRIBUTABLE RISK FOR CORONARY HEART DISEASE: ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY
43. LEFT VENTRICLE MASS IS ASSOCIATED WITH OBSTRUCTIVE SLEEP APNEA SEVERITY IN PATIENTS WITH CARDIOVASCULAR DISEASE OR SIGNIFICANT RISK FACTORS
44. RESTING HEART RATE AND CHANGES IN HEART RATE ARE ASSOCIATED WITH ADVERSE OUTCOME IN HEART FAILURE PATIENTS WITHOUT ATRIAL FIBRILLATION: AN ANALYSIS OF THE CHARM PROGRAM
45. PROGNOSTIC VALUE OF CORONARY CTA VERSUS EXERCISE TREADMILL TESTING
46. Yield of Downstream Tests After Exercise Treadmill Testing
47. Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis
48. PRAISE (Prospective Randomized Amlodipine Survival Evaluation) and Criticism ∗
49. Risk Stratification of Resistant Hypertension in Chronic Kidney Disease
50. IMPACT OF REFERRING PHYSICIAN SPECIALTY ON DOWNSTREAM TESTING AFTER EXERCISE TREADMILL TESTING
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.